Most Recent
Enviro group takes Tamboran to court over Beetaloo Basin fracking
Environmental activists claim fracking by natural gas company Tamboran in the Northern Territory's Beetaloo Basin risks contaminating groundwater. 
Construction PRO
Sister of concrete king can access company’s books, court rules
The heir to a Queensland concrete empire has been granted access to Neilsen Group's books following a dispute with her brother over the company's operations that resulted in her appointment as a director.
High Court ends Commonwealth’s quest for $325M over generic Plavix ban
The High Court has settled a 16-year battle between the federal government and Sanofi over alleged excess subsidies it paid after a judge blocked the release of a generic version of blood thinner Plavix, saying its job was not to “resurrect” a dead case.
High Court cases could push Blue Sky class action trial to 2026
Two High Court cases weighing key issues for class action practitioners will likely push the trial in a shareholder proceeding against the collapsed Blue Sky Alternative Investments and auditor EY to early 2026. 
Velocity Rewards joined to Virgin class action despite ‘barely arguable’ claim
A judge has allowed investors bringing a class action against Virgin to join Velocity Rewards to the case, despite finding the proposed claims against the frequent flyer program are “barely arguable”. 
Virgin bondholders want to join Velocity Rewards to class action
A class action against Virgin Australia wants to drag Velocity Rewards into the case, claiming the frequent flyer program was involved in misleading investors about $460 million in funds on Virgin’s balance sheet.
‘Contingency on contingency’: Judge won’t halt IP dispute over Abilify generic
The Commonwealth has lost its bid to pause a long-running dispute over a generic form of brand drug Abilify while the High Court hears a different generic drug battle.
Government wants to stay 12-year-old dispute over Abilify generic
The Commonwealth has argued that a long-running dispute involving drug makers Otsuka, Bristol-Myers Squibb and Generic Health should be put on ice until the High Court rules in a separate matter.
Media mogul says costs spat should be put on ice until High Court rules
Media mogul Bruce Gordon says a costs dispute with Atanaskovic Hartnell should be paused until the High Court has its say on a key issue.